Almost no other industry goes as far as the phrase "defensive" as the healthcare sector, which encompasses a wide range of ...

Cholesterol is an important part of your body’s health, but too much of the wrong kind can lead to serious problems like ...

Recent innovations in DNA-modifying will revolutionize the treatment of many diseases and prompt crucial discussions.

Q. Allergan ran a long-term study on silicone breast implants in 2009. I always wanted a more feminine body like the girls in the magazines, so I joined and got implants. They never followed up with ...

Evolucumab (Repatha) and alirocumab (Praluent) are injectable monoclonal antibodies. They have been joined by inclisiran ...

Updated guidance on preventing atherosclerotic cardiovascular disease in people with dyslipidemia includes changes reflecting ...

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...

Amgen, Inc. ( NASDAQ: AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ET Narimon Honarpour - Senior Vice President, Global Development Justin Claeys - ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Scientists are sounding the alarm over the so-called 'good cholesterol', after findings suggest that it may not be entirely beneficial. Despite a positive reputation, recent research has unveiled ...

I think it’s absurd that the stock, once again, sells for 14 times earnings. The flagship drug is Repatha, which is the best ...

Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs ...